Marker for endometrial cancer and detection kit thereof
A technology for endometrial cancer, detection kits, applied in the direction of determination/inspection of microorganisms, biochemical equipment and methods, DNA/RNA fragments, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Example 1 Screening of the lncRNA system associated with the prognosis of endometrial cancer
[0040] Use bioinformatics analysis methods to find lncRNAs that are closely related to the occurrence and clinical prognosis of endometrial cancer, and discover and improve the lncRNAs system that can be used for the diagnosis and prognosis of endometrial cancer.
[0041]Extract the RNA expression profile and clinical information data (https: / / portal.gdc.cancer.gov / repository) of all endometrial cancer (UterineCorpus Endometrial Carcinoma, UCEC) in the (The Cancer Genome Atlas (TCGA)) database, including 548 UCEC tissues and 35 non-tumor tissues. LncRNAs are annotated by the human gene annotation file (GRCh38.p12), which has been downloaded from the Ensembl database (https: / / asia.ensembl.org / index.html). The expression data of lncRNAs were analyzed and intersected by R / Bioconductor software packages Limma, edgeR, and DESeq2. Differentially expressed lncRNAs were distinguishe...
Embodiment 2
[0050] Example 2 Detection of the expression level of 3-lncRNAs in tumor tissues of patients with endometrial cancer
[0051] The samples of endometrial cancer patients admitted to the Department of Obstetrics and Gynecology of the First Affiliated Hospital of Soochow University were collected, relevant clinical data were analyzed, and the real time RT-PCR method was used to detect lnc02086, lncFAM83D and lncARL6- 1, using GAPDH as an internal reference.
[0052] The primer sequences used to detect lnc02086, lncFAM83D, lncARL6-1, and GAPDH are as follows:
[0053] lnc02086-F: 5'-TTCCGGTGTCCAGATGTTCA-3'; SEQ ID NO.4;
[0054] lnc02086-R: 5'-AAGGTGAGTTGGGGAGGATG-3'; SEQ ID NO.5;
[0055] lncFAM83D-F: 5'-ATGAGTGTGGCAGCCTATGT-3'; SEQ ID NO.6;
[0056] lncFAM83D-R: 5'-AACTCCTGACCTCGTGATCC-3'; SEQ ID NO.7;
[0057] lncARL6-1-F: 5'-GGCCTTGAGAGATAGAGGGG-3'; SEQ ID NO.8;
[0058] lncARL6-1-R: 5'-ATACGTCCTTTCCCATCCTGC-3'; SEQ ID NO.9;
[0059] GAPDH-F: 5'-GCACAGTCAAGGCTGAGAATG-3';...
Embodiment 33-l
[0062] Correlation between the expression level of embodiment 33-lncRNAs and the clinical characteristics of endometrial cancer
[0063] In order to investigate the correlation between the expression level of 3-lncRNAs and the clinical features of endometrial cancer, according to the expression levels of lnc02086 (CTD_2377D24.6), lncFAM83D (RP4_616B8.5) and lncARL6-1 (RP11_389G6.3), the uterine Endometrial cancer patients were divided into 3-lncRNAs high expression level group and 3-lncRNAs low expression level group. The results of Pearsonchi-square and Fisher's Exact tests analysis showed that the expression level of 3-lncRNAs was related to the histological type of endometrial cancer, menopausal , clinical stage and tumor are closely related (Table 2), which provides a reliable research basis for future prospective research on the expression level of 3-lncRNAs and the clinical characteristics of endometrial cancer.
[0064] Table 2 Three sets of long non-coding RNAs are sig...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com